Intravesical nitric oxide delivery for prevention of catheter-associated urinary tract infections

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 6, 2005, Pages 2352-2355

  Carlsson, Stefan ^a   Weitzberg, Eddie ^a   Wiklund, Peter ^a   Lundberg, Jon O ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ASCORBIC ACID; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ESCHERICHIA COLI; INDWELLING CATHETER; NONHUMAN; PRIORITY JOURNAL; URINARY TRACT INFECTION;

ADMINISTRATION, INTRAVESICAL; ANTI-BACTERIAL AGENTS; ASCORBIC ACID; CATHETERS, INDWELLING; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; LABORATORIES; MODELS, ANATOMIC; NITRIC OXIDE; NITRITES; URINARY BLADDER; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS; URINE;

EID: 19544395027     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.6.2352-2355.2005     Document Type: Article

References (19)

1. Badawi, A. F. 2000. Nitrate, nitrite and N-nitroso compounds in human bladder cancer associated with schistosomiasis. Int. J. Cancer 86:598-600.
2. Bjorne, H. H., et al. 2004. Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. J. Clin. Investig. 113:106-114.
3. Brandt, R., K. E. Guyer, and W. L. Banks, Jr. 1977. Urinary glucose and vitamin C. Am. J. Clin. Pathol. 68:592-594.
4. Carlsson, S., et al. 2003. In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria. Antimicrob. Agents Chemother. 47:3713-3718.
5. Carlsson, S., et al. 2001. Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide 5:580-586.
6. Fang, F. C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Investig. 99:2818-2825.
7. Feelisch, M. 1998. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch. Pharmacol. 358:113-122.
8. Lundberg, J. O., et al. 2004. Nitrate, bacteria and human health. Nat. Rev. Microbiol. 2:593-602.
9. Lundberg, J. O., and M. Govoni. 2004. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radical Biol. Med. 37:395-400.
10. Maki, D. G., and P. A. Tambyah. 2001. Engineering out the risk for infection with urinary catheters. Emerg. Infect. Dis. 7:342-347.
11. Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Investig. 100:2417-2423.
12. Parkin, J., and F. X. Keeley. 2003. Indwelling catheter-associated urinary tract infections. Br. J. Community Nurs. 8:166-167, 170-171.
13. Poock, S. R., et al. 2002. Respiratory detoxification of nitric oxide by the cytochrome c nitrite reductase of Escherichia coli. J. Biol. Chem. 277:23664-23669.
14. Poole, R. K., et al. 1996. Nitric oxide, nitrite, and Fnr regulation of hmp (flavohemoglobin) gene expression in Escherichia coli K-12. J. Bacteriol. 178:5487-5492.
15. Poole, R. K., and M. N. Hughes. 2000. New functions for the ancient globin family: bacterial responses to nitric oxide and nitrosative stress. Mol. Microbiol. 36:775-783.
16. Richards, M. J., et al. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27:887-892.
17. Stickler, D. J., G. L. Jones, and A. D. Russell. 2003. Control of encrustation and blockage of Foley catheters. Lancet 361:1435-1437.
18. Trautner, B. W., and R. O. Darouiche 2004. Catheter-associated infections: pathogenesis affects prevention. Arch. Intern. Med. 164:842-850.
19. Weitzberg, E., and J. O. Lundberg. 1998. Nonenzymatic nitric oxide production in humans. Nitric Oxide 2:1-7.